CTKB

CYTEK BIOSCIENCES, INC.

CTKB · CIK 1831915 · Annual (10-K) · Last 5 years

Financial Trends

Revenue$201M
20212025
Net Income−$67M
20212025
Operating CF−$5M
20212025
Free Cash Flow−$9M
20212025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue$0.2B$0.2B$0.2B$0.2B$0.1B
Cost of Revenue$0.1B$0.1B$0.1B$0.1B$0.0B
Gross Profit$0.1B$0.1B$0.1B$0.1B$0.1B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense—————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$0.0B
Net Income$-0.1B$-0.0B$-0.0B$0.0B$0.0B
EPS (Basic)——$-0.09$0.02$0.00
EPS (Diluted)——$-0.09$0.02$0.00

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.5B$0.5B$0.5B$0.5B$0.5B
Current Assets$0.4B$0.4B$0.4B$0.5B$0.4B
Cash & Equivalents$0.1B$0.1B$0.2B$0.3B$0.4B
Total Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.0B
Stockholders' Equity$0.3B$0.4B$0.4B$0.4B$0.4B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$0.0B$0.0B$-0.0B$0.0B
Investing Cash Flow$0.0B$-0.1B$-0.1B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.0B$-0.0B$-0.0B$0.0B$0.2B
← Companies